It is important to involve patients and the public in pharmaceutical medicines research and development. Suzanne Parsons and Bella Starling examine who is interested, who is not and why. Involving patients and the public as active partners in their healthcare and in healthcare research has become an increasingly important policy issue in the last two […]
Why it’s time for us to spend big on science
In his recent party conference speech, Science Minister David Willetts said he was ‘up for’ making Britain the best place in the world to do science. But in order to do that – and reap the economic rewards – politicians need to be prepared to spend big, argues Professor Brian Cox. This blog post is […]